InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by GUGGENHIME ANDREW, Chief Financial Officer. Insider active across 1 companies, notably Vaxcyte, Inc.. Cumulatively, 9 disclosures have been logged. The latest transaction was disclosed on 18 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€15,8363,100 shares@ €5.10850.0003% mcap11.8% of flow
Common Stock
SEC:0001209191-22-031062:0·
€15,3823,100 shares@ €4.96210.0003% mcap11.5% of flow
Common Stock
SEC:0001209191-22-025012:0·
€14,9423,100 shares@ €4.820.0002% mcap11.1% of flow
Common Stock
SEC:0001209191-22-020525:0·
037,500 shares0
Common Stock
SEC:0001209191-22-016521:0·
€29,5746,200 shares@ €4.770.0005% mcap22.0% of flow
Common Stock
SEC:0001209191-22-015477:0·
€14,6403,100 shares@ €4.72240.0002% mcap50.0% of flow
Common Stock
SEC:0001209191-21-071374·
€14,6403,100 shares@ €4.72240.0002% mcap10.9% of flow
Common Stock
SEC:0001209191-21-071374:0·
€14,6503,100 shares@ €4.72570.0002% mcap50.0% of flow
Common Stock
SEC:0001209191-21-066126·
€14,6503,100 shares@ €4.72570.0002% mcap10.9% of flow
Common Stock
SEC:0001209191-21-066126:0·
9 of 9 declarations
About GUGGENHIME ANDREW
GUGGENHIME ANDREW is the President and Chief Financial Officer of Vaxcyte, Inc. He oversees the company's financial management, including budgeting and performance analysis.
